Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Healthcare Company (ACHC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to 10.43%.

  • Acadia Healthcare Company's EBITDA Margin fell 87600.0% to 10.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.83%, marking a year-over-year decrease of 96400.0%. This contributed to the annual value of 1.61% for FY2024, which is 112300.0% up from last year.
  • As of Q3 2025, Acadia Healthcare Company's EBITDA Margin stood at 10.43%, which was down 87600.0% from 9.71% recorded in Q2 2025.
  • In the past 5 years, Acadia Healthcare Company's EBITDA Margin ranged from a high of 3.79% in Q2 2022 and a low of 52.17% during Q3 2023
  • Moreover, its 5-year median value for EBITDA Margin was 0.87% (2022), whereas its average is 5.38%.
  • In the last 5 years, Acadia Healthcare Company's EBITDA Margin plummeted by -533900bps in 2023 and then skyrocketed by 505100bps in 2024.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's EBITDA Margin stood at 2.87% in 2021, then tumbled by -130bps to 0.87% in 2022, then tumbled by -182bps to 2.44% in 2023, then tumbled by -322bps to 10.32% in 2024, then dropped by -1bps to 10.43% in 2025.
  • Its EBITDA Margin was 10.43% in Q3 2025, compared to 9.71% in Q2 2025 and 13.05% in Q1 2025.